High Court considers requirements for an exclusive patent licence (Neurim v Mylan)

In the LexisNexis case analysis, Senior IP Associate, Will Smith, talks about the decision in the following matter: Neurim Pharmaceuticals (1991) Ltd & Anor v Generics UK Ltd (t\a MYLAN) [2020] EWHC 3270 (Pat). This case concerned the licensing of patented technology, specifically the use of licence terms relating to the control of proceedings. 

Click here to read more >

Full article available on PatentHub

Latest insights

More Insights
Folder

Investing in data centres: understanding Permanent Establishment issues

Sep 19 2024

Read More
Server Room Corridor

The Rise of Data Centres in Spain

Sep 19 2024

Read More
high vis

Challenges to the development of new data centres in Germany

Sep 19 2024

Read More